A split-face study evaluating the efficacy of a topical antioxidant cream containing tocotrienol after 1064-nm picosecond Nd:YAG laser treatment for environment-induced skin pigmentation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang, Moon Seok | - |
dc.contributor.author | Kim, Jun Hyun | - |
dc.contributor.author | Nam, Seung Min | - |
dc.contributor.author | Park, Eun Soo | - |
dc.date.accessioned | 2021-09-10T05:45:20Z | - |
dc.date.available | 2021-09-10T05:45:20Z | - |
dc.date.issued | 2021-07 | - |
dc.identifier.issn | 2234-0831 | - |
dc.identifier.issn | 2288-9337 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/18727 | - |
dc.description.abstract | Background This study aimed to evaluate the efficacy and safety of a topical antioxidant cream containing tocotrienol after 1064-nm picosecond neodymium-doped yttrium aluminum garnet (Nd:YAG) laser treatment for environment-induced skin pigmentation. Methods A split-face study was conducted between December 2020 and March 2021 in 26 patients (25 women and one man) who were treated with a 1064-nm picosecond Nd:YAG laser. On the right side of the face, an antioxidant cream containing tocotrienol was applied after picosecond laser treatment, and on the left side, only picosecond laser treatment was performed. We compared the right and left sides of the face at 4 weeks after laser treatment using an automatic skin analysis device to investigate skin pigmentation. The melasma severity scores of the two sides were evaluated before and 4 weeks after picosecond laser treatment. Results The skin pigmentation score showed a significant difference between pretreatment and 4 weeks after picosecond laser treatment on both sides of the face (P<0.001), and there was a significant difference in skin pigmentation score improvement between the right and left sides (P<0.001). The melasma severity score showed a significant difference on the right side between pretreatment and 4 weeks after laser treatment (P<0.001), but there was no significant change on the left side (P>0.05). Conclusions Our results show that, for the treatment of environment-induced skin pigmentation, the application of a tocotrienol-containing antioxidant cream after-1064-nm picosecond laser treatment can provide good results without any complications. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한미용성형외과학회 | - |
dc.title | A split-face study evaluating the efficacy of a topical antioxidant cream containing tocotrienol after 1064-nm picosecond Nd:YAG laser treatment for environment-induced skin pigmentation | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.14730/aaps.2021.00143 | - |
dc.identifier.wosid | 000680236200004 | - |
dc.identifier.bibliographicCitation | Archives of Aesthetic Plastic Surgery, v.27, no.3, pp 100 - 105 | - |
dc.citation.title | Archives of Aesthetic Plastic Surgery | - |
dc.citation.volume | 27 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 100 | - |
dc.citation.endPage | 105 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002741376 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | esci | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | MELASMA | - |
dc.subject.keywordPlus | ACID | - |
dc.subject.keywordAuthor | Laser | - |
dc.subject.keywordAuthor | Pigmentation | - |
dc.subject.keywordAuthor | Antioxidants | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.